Resource Effective Strategies to Prevent and Treat Cardiovascular Disease.
暂无分享,去创建一个
[1] S. Yusuf,et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data , 2016, The Lancet.
[2] S. Yusuf,et al. The environmental profile of a community’s health: a cross-sectional study on tobacco marketing in 16 countries , 2015, Bulletin of the World Health Organization.
[3] S. Yusuf,et al. Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach , 2015, BMC Health Services Research.
[4] S. Yusuf,et al. Adapting the World Heart Federation Roadmaps at the National Level: Next Steps and Conclusions. , 2015, Global Heart.
[5] S. Yusuf,et al. Reducing Premature Cardiovascular Mortality By 2025: The World Heart Federation Roadmap. , 2015, Global Heart.
[6] S. Yusuf,et al. Reducing Cardiovascular Disease Globally: The World Heart Federation's Roadmaps. , 2015, Global heart.
[7] H. Mamudu,et al. A Chilling Example? Uruguay, Philip Morris International, and WHO's Framework Convention on Tobacco Control. , 2015, Medical anthropology quarterly.
[8] Mark D. Huffman,et al. Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease. , 2015, Global heart.
[9] A. Reeves,et al. Financing universal health coverage—effects of alternative tax structures on public health systems: cross-national modelling in 89 low-income and middle-income countries , 2015, The Lancet.
[10] Andrew E Moran,et al. Demographic and epidemiologic drivers of global cardiovascular mortality. , 2015, The New England journal of medicine.
[11] Abigail S. Baldridge,et al. Disparities in Cardiovascular Research Output and Citations From 52 African Countries: A Time‐Trend, Bibliometric Analysis (1999–2008) , 2015, Journal of the American Heart Association.
[12] K. Charlton,et al. A cross-sectional analysis of the cost and affordability of achieving recommended intakes of non-starchy fruits and vegetables in the capital of Vanuatu , 2015, BMC Public Health.
[13] S. Bialous,et al. Exposing and addressing tobacco industry conduct in low-income and middle-income countries , 2015, The Lancet.
[14] Lisa Rosenbaum. Beyond belief--how people feel about taking medications for heart disease. , 2015, The New England journal of medicine.
[15] Bruce Neal,et al. Effect of a Computer-Guided, Quality Improvement Program for Cardiovascular Disease Risk Management in Primary Health Care: The Treatment of Cardiovascular Risk Using Electronic Decision Support Cluster-Randomized Trial , 2015, Circulation. Cardiovascular quality and outcomes.
[16] S. Chatterjee,et al. Cost-effectiveness of treatment and secondary prevention of acute myocardial infarction in India: a modeling study. , 2014, Global heart.
[17] Martin McKee,et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. , 2014, The New England journal of medicine.
[18] Stephen Jan,et al. Task Shifting for Non-Communicable Disease Management in Low and Middle Income Countries – A Systematic Review , 2014, PloS one.
[19] R. Marten,et al. An assessment of progress towards universal health coverage in Brazil, Russia, India, China, and South Africa (BRICS) , 2014, The Lancet.
[20] C. Murray,et al. The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study , 2014, Circulation.
[21] N. Sarrafzadegan,et al. Utilization of evidence-based therapy for acute coronary syndrome in high-income and low/middle-income countries. , 2014, The American journal of cardiology.
[22] Jackson T. Wright,et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.
[23] S. Yusuf,et al. Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies , 2014, PloS one.
[24] Alexandra Wollum,et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. , 2014, JAMA.
[25] M. Weinstein,et al. Who Needs Laboratories and Who Needs Statins?: Comparative and Cost-Effectiveness Analyses of Non–Laboratory-Based, Laboratory-Based, and Staged Primary Cardiovascular Disease Screening Guidelines , 2014, Circulation. Cardiovascular quality and outcomes.
[26] J. Bosch,et al. Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. , 2013, European Heart Journal.
[27] Martin McKee,et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. , 2013, JAMA.
[28] D. Prabhakaran,et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. , 2013, JAMA.
[29] Mark D. Huffman,et al. Trends in Vascular Risk Factor Treatment and Control in US Stroke Survivors: The National Health and Nutrition Examination Surveys (1999–2010) , 2013, Circulation. Cardiovascular quality and outcomes.
[30] Wei Li,et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study. , 2013, JAMA.
[31] Dolores Corella,et al. Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013, The New England journal of medicine.
[32] D. Wald,et al. Randomized Polypill Crossover Trial in People Aged 50 and Over , 2012, PloS one.
[33] S. Yusuf,et al. Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases: The Second Indian Polycap Study (TIPS-2) Investigators , 2012, Circulation. Cardiovascular quality and outcomes.
[34] M. Mckee,et al. Manufacturing Epidemics: The Role of Global Producers in Increased Consumption of Unhealthy Commodities Including Processed Foods, Alcohol, and Tobacco , 2012, PLoS medicine.
[35] J. Grimshaw,et al. Knowledge translation of research findings , 2012, Implementation Science.
[36] M. Mckee,et al. Where There Is No Health Research: What Can Be Done to Fill the Global Gaps in Health Research? , 2012, PLoS medicine.
[37] Stephen S. Lim,et al. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study , 2012, BMJ : British Medical Journal.
[38] S. Kumanyika,et al. Behavioral Strategies for Cardiovascular Risk Reduction in Diverse and Underserved Racial/Ethnic Groups , 2012, Circulation.
[39] T. Brennan,et al. Full coverage for preventive medications after myocardial infarction. , 2011, The New England journal of medicine.
[40] M. Hill,et al. Community Outreach and Cardiovascular Health (COACH) Trial: A Randomized, Controlled Trial of Nurse Practitioner/Community Health Worker Cardiovascular Disease Risk Reduction in Urban Community Health Centers , 2011, Circulation. Cardiovascular quality and outcomes.
[41] S. Yusuf,et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey , 2011, The Lancet.
[42] R. Murray,et al. What Factors Influence Smoking Prevalence and Smoke Free Policy Enactment across the European Union Member States , 2011, PloS one.
[43] P. Lindsay,et al. Canadian Hypertension Education Program: the science supporting New 2011 CHEP recommendations with an emphasis on health advocacy and knowledge translation. , 2011, The Canadian journal of cardiology.
[44] Mark D. Huffman,et al. A Cross-Sectional Study of the Microeconomic Impact of Cardiovascular Disease Hospitalization in Four Low- and Middle-Income Countries , 2011, PloS one.
[45] T. Novotny,et al. UN resolution on the prevention and control of non-communicable diseases: An opportunity for global action , 2011, Global public health.
[46] N. Steyn,et al. The cost of a healthy diet: a South African perspective. , 2011, Nutrition.
[47] Martin McKee,et al. Priority actions for the non-communicable disease crisis , 2011, The Lancet.
[48] R. Collins,et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. , 2011, The New England journal of medicine.
[49] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.
[50] Michele Cecchini,et al. Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness , 2010, The Lancet.
[51] Hayden B Bosworth,et al. Patient self-management support: novel strategies in hypertension and heart disease. , 2010, Cardiology clinics.
[52] A. Yan,et al. Optimal Medical Therapy for Non–ST-Segment–Elevation Acute Coronary Syndromes: Exploring Why Physicians Do Not Prescribe Evidence-Based Treatment and Why Patients Discontinue Medications After Discharge , 2010, Circulation. Cardiovascular quality and outcomes.
[53] C. Clark,et al. Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.
[54] S. Yusuf,et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.
[55] P. Volberding,et al. Antiretroviral therapy and management of HIV infection , 2010, The Lancet.
[56] N. Ford,et al. A systematic review of task- shifting for HIV treatment and care in Africa , 2010, Human resources for health.
[57] Tezeta F. Mitiku,et al. Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors , 2009, Canadian Medical Association Journal.
[58] T. Ahmed,et al. Community-based skilled birth attendants in Bangladesh: attending deliveries at home , 2009, Reproductive health matters.
[59] S. Leeder,et al. Coronary heart disease epidemics: not all the same , 2008, Heart.
[60] P. Austin,et al. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction , 2008, Canadian Medical Association Journal.
[61] C. Mathers,et al. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use , 2007, The Lancet.
[62] F. Farzadfar,et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs , 2007, The Lancet.
[63] Simon Capewell,et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.
[64] S. Nishtar,et al. Can non-physician health-care workers assess and manage cardiovascular risk in primary care? , 2007, Bulletin of the World Health Organization.
[65] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[66] Piotr Ponikowski,et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.
[67] Guilbert Jj. The World Health Report 2006: working together for health. , 2006 .
[68] Murray Stewart,et al. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[69] Milton C Weinstein,et al. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis , 2006, The Lancet.
[70] G. Guyatt,et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. , 2006, JAMA.
[71] J. Wylie-Rosett,et al. Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee , 2006, Circulation.
[72] S. Yusuf,et al. WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). , 2005, Bulletin of the World Health Organization.
[73] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[74] M. Jacobs,et al. Human resources for health: overcoming the crisis , 2004, The Lancet.
[75] John X. Morris,et al. The Fat of the Land: Do Agricultural Subsidies Foster Poor Health? , 2004, Environmental Health Perspectives.
[76] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[77] A. Fendrick,et al. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations , 2004, Journal of General Internal Medicine.
[78] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[79] F. Turnbull. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.
[80] A. Dyer,et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. , 2003, JAMA.
[81] A. Dyer,et al. Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events , 2003 .
[82] Christopher J L Murray,et al. WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty , 2003, BMJ : British Medical Journal.
[83] D. Yach. WHO Framework Convention on Tobacco Control , 2003, The Lancet.
[84] O. Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[85] R Brian Haynes,et al. Helping patients follow prescribed treatment: clinical applications. , 2002, JAMA.
[86] S. Yusuf. Two decades of progress in preventing vascular disease , 2002, The Lancet.
[87] B. MacLeod,et al. Demographic surveillance and health equity in sub-Saharan Africa. , 2001, Health policy and planning.
[88] S. Yusuf,et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.
[89] I D Graham,et al. The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[90] M. Cabana,et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.
[91] L. Wexler,et al. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care. , 1995 .
[92] C. Bunker,et al. Adequacy of a single visit for classification of hypertensive status in a Nigerian civil servant population. , 1994, International journal of epidemiology.
[93] E. Vartiainen,et al. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland , 1994, BMJ.
[94] B. Glaser. The Constant Comparative Method of Qualitative Analysis , 1965 .
[95] P. Hill,et al. Universal Health Coverage and the Right to Health: From Legal Principle to Post-2015 Indicators , 2015 .
[96] S. Yusuf,et al. Controversies in cardiovascular medicine Why are we failing to implement effective therapies in cardiovascular disease ? , 2013 .
[97] Mark D. Huffman,et al. Fixed-dose combination therapy for the prevention of cardiovascular disease. , 2012, The Cochrane database of systematic reviews.
[98] Vilmundur Gudnason,et al. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .
[99] L. Shaw,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.
[100] W. J. Elliott,et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial , 2010 .
[101] Organización Mundial de la Salud. WHO report on the global tobacco epidemic, 2009: implementing smoke-free environments , 2009 .
[102] Y. Swica,et al. Proposal for the inclusion of misoprostol in the WHO model list of essential medicines , 2009 .
[103] TAkING STOCk,et al. Task shifting to tackle health worker shortages , 2007 .
[104] S. Flottorp,et al. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. , 2005, The Cochrane database of systematic reviews.
[105] J. Crofton,et al. Tobacco and the developing world. , 1996, British medical bulletin.